Study Information

Alliance Study ID: A221304

NCT Study ID (ClinicalTrials.gov): NCT02229539

Alliance Committee: Cancer Control

Disease or Cancer Type: Head & Neck Cancers

Alliance Study Chair: Robert Miller, MD, MS

Status: COMPLETED


Study Description

The purpose of this study is to test whether a mouthwash made with a drug called doxepin can reduce the pain caused by mouth sores resulting from radiation therapy. A number of mouth rinse preparations exist for patients with treatment-related oral mucositis pain such as the DLA rinse, an over-the-counter medication. This study will evaluate the effects of doxepin compared to DLA (diphenhydramine, lidocaine and antacids) and placebo.Doxepin is approved by the Food and Drug Administration (FDA) for the treatment of depression, anxiety, long-term pain management, as well as management of rash.

Related Publications

For publications related to this and other clinical trials, visit the Alliance Publications Application.

Data Sources & Contacts

Related Alliance Trials